Does BioLife Solutions (BLFS) Have the Potential to Rally 25.6% as Wall Street Analysts Expect?
The consensus price target hints at a 25.6% upside potential for BioLife Solutions (BLFS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·8d ago
More News
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
Despite industry headwinds, Envista, BioLife Solutions, InfuSystems and MariMed are leveraging innovation and strategy for growth.
Zacks·22d ago
4 Medical Product Stocks to Watch From a Challenging Industry
The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.
Zacks·23d ago
BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why
BioLife Solutions (BLFS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·25d ago
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know
The mean of analysts' price targets for BioLife Solutions (BLFS) points to a 39.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·25d ago
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
BioLife Solutions (BLFS) delivered earnings and revenue surprises of +100.00% and +6.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·30d ago
MariMed Inc. (MRMD) Reports Break-Even Earnings for Q2
MariMed Inc. (MRMD) delivered earnings and revenue surprises of +100.00% and -2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
Ensign Group Boosts U.S. Presence With Idaho and Texas Facility Buyouts
ENSG adds Idaho and Texas facilities to its skilled nursing facility and real estate portfolios and earns an opportunity to boost revenues by catering to growing patient volumes.
Zacks·2mo ago
How Much Upside is Left in BioLife Solutions (BLFS)? Wall Street Analysts Think 41.72%
Zacks·3mo ago
EHC Opens Rehabilitation Unit in Fort Myers, Boosts Florida Footprint